nivolumab
Pronunciation: nye-VOL-ue-mab
Other Name(s): Opdivo®
Apparence: solution mixed into larger bags of fluids
Les renseignements du Formulaire de médicaments s’adressent aux professionnels de la santé. Il ne s’agit pas d’un avis médical. Certains des renseignements, y compris ceux sur le financement des médicaments anticancéreux, ne s’appliquent pas à tous les patients. Les plans de traitement du cancer sont propres à chaque patient. Si vous êtes un patient, veuillez parler avec votre équipe soignante pour comprendre comment ces renseignements s’appliquent à vous.
Drug Monograph
déc 2025
Eligibility Forms
Nivolumab - Advanced Melanoma (Unresectable or Metastatic Melanoma) Nivolumab - Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck, which is Platinum Resistant or Refractory Nivolumab - Relapsed Classical Hodgkin Lymphoma (cHL) Post-Autologous Stem Cell Transplant (ASCT) or ASCT Ineligible Nivolumab - Advanced or Metastatic Non-Small Cell Lung Cancer Nivolumab plus Ipilimumab - Advanced Malignant Pleural Mesothelioma Nivolumab plus Ipilimumab - In Combo with Platinum Doublet Chemo for First Line Metastatic or Recurrent NSCLC Nivolumab - First-line Treatment of Advanced Gastric Esophageal and Esophagogastric Junction Adenocarcinoma Nivolumab - Adjuvant Treatment of Completely Resected Esophageal or Esophagogastric Junction Cancer Nivolumab plus Ipilimumab - Metastatic Renal Cell Carcinoma Nivolumab - Advanced or Metastatic Renal Cell Carcinoma and Prior mTOR Inhibitor Nivolumab - Advanced or Metastatic Renal Cell Carcinoma and No Prior mTOR Inhibitor Nivolumab - Adjuvant Treatment of Urothelial Carcinoma Nivolumab - Neoadjuvant Treatment for Non-Small Cell Lung Cancer Nivolumab - In Combination with Cabozantinib for First Line Advanced or Metastatic Renal Cell Carcinoma Nivolumab plus Ipilimumab - (Neo)adjuvant Resectable Macroscopic Stage III Melanoma Nivolumab - Adjuvant Treatment for Completely Resected Stage IIB or IIC Melanoma Nivolumab - Adjuvant Treatment for Completely Resected Stage III or IV Melanoma Nivolumab plus Ipilimumab - MSI-H dMMR Locally Advanced Unresectable or Metastatic Colorectal Cancer.pdfPatient Info Sheet
mar 2023
What it is used for
- For treating many types of cancers such as melanoma (skin), lung, renal cell (kidney), colorectal, liver, head and neck, Hodgkin lymphoma, mesothelioma and others
- Nivolumab is an immunotherapy drug. For more information on immunotherapy, click here.